Search hospitals > Colorado > Denver
Rose Medical Center
Claim this profileDenver, Colorado 80220
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Leukemia
Conducts research for Lymphoma
293 reported clinical trials
3 medical researchers
Summary
Rose Medical Center is a medical facility located in Denver, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Leukemia, Lymphoma and other specialties. Rose Medical Center is involved with conducting 293 clinical trials across 403 conditions. There are 3 research doctors associated with this hospital, such as Nicholas DiBella, Keren Sturtz, and Andrew S. Kennedy.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
Stage IV
HER2 negative
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder5 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
103 reported clinical trials
193 drugs studied
Keren SturtzSCL Health Lutheran Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Carcinoma
4 reported clinical trials
14 drugs studied
Andrew S. KennedyMission Hospital1 year of reported clinical research
Studies Breast Cancer
Studies Recurrence
3 reported clinical trials
18 drugs studied
Clinical Trials running at Rose Medical Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Melanoma
Cutaneous Melanoma
Bladder Cancer
Cancer
Skin Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Questionnaire Choice
for Cancer Data Quality
The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.
Recruiting1 award N/A11 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rose Medical Center?
Rose Medical Center is a medical facility located in Denver, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Leukemia, Lymphoma and other specialties. Rose Medical Center is involved with conducting 293 clinical trials across 403 conditions. There are 3 research doctors associated with this hospital, such as Nicholas DiBella, Keren Sturtz, and Andrew S. Kennedy.